nitazoxanide has been researched along with metronidazole in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.96) | 18.2507 |
2000's | 18 (35.29) | 29.6817 |
2010's | 25 (49.02) | 24.3611 |
2020's | 7 (13.73) | 2.80 |
Authors | Studies |
---|---|
Cremades, N; Croxen, MA; Harman, WD; Hoffman, PS; Morash, MG; Sisson, G; Welch, K | 1 |
Hemphill, A; Müller, J; Müller, N; Sanderson, S; Wastling, J | 1 |
Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP | 1 |
Argotte-Ramos, R; Cedillo-Rivera, R; Chan-Bacab, MJ; Chávez-Silva, F; Hernández-Nuñez, E; Moo-Puc, R; Navarrete-Vazquez, G; Rodríguez-Gutiérrez, Mdel C | 1 |
Duque-Montaño, BE; Gómez-Caro, LC; Hernández-Baltazar, E; Monge, A; Rivera, G; Sanchez-Sanchez, M; Torres-Angeles, O | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chan-Bacab, MJ; Chávez-Silva, F; Díaz-Coutiño, D; Hernández-Núñez, E; Moo-Puc, R; Moreno-Díaz, H; Nava-Zuazo, C; Navarrete-Vázquez, G; Ortega-Morales, BO | 1 |
Canul-Canché, J; Chávez-Silva, F; Colín-Lozano, B; Estrada-Soto, S; Guerrero-Álvarez, J; Hidalgo-Figueroa, S; Méndez, ST; Moo-Puc, R; Navarrete-Vázquez, G; Oria-Hernández, J; Ortiz-Andrade, R; Reyes-Vivas, H | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Argüello-Garcia, R; Barbosa-Cabrera, E; Chan-Bacab, MJ; Colín-Lozano, B; Hernández-Núñez, E; León-Rivera, I; López-Guerrero, V; Moo-Puc, R; Navarrete-Vázquez, G; Ortega-Morales, BO; Scior, T | 1 |
Hart, CJS; Riches, A; Skinner-Adams, TS; Trenholme, KR | 1 |
Cortés-Benítez, F; Palacios-Espinosa, JF; Pérez-Villanueva, J; Rodríguez-Villar, K; Soria-Arteche, O; Yépez-Mulia, L | 1 |
Mégraud, F; Occhialini, A; Rossignol, JF | 1 |
Vdovenko, AA; Williams, JE | 1 |
McVay, CS; Rolfe, RD | 1 |
Abboud, P; Ballet, JJ; Borsa-Lebas, F; Brasseur, P; Caron, F; Favennec, L; Gargala, G; Lemée, V | 1 |
Ayoub, A; Chegne, NL; Favennec, L; Gargala, G; Ortiz, JJ | 1 |
Berg, DE; Goodwin, A; Hoffman, PS; Hughes, NJ; Mukhopadhyay, AK; Raudonikiene, A; Sisson, G | 1 |
Hemphill, A; Müller, J; Müller, N; Rossignol, JF; Rühle, G | 1 |
Appelbaum, PC; Pankuch, GA | 1 |
Dupont, HL; Gupta, A; Hamill, RJ; Lentnek, A; Logan, N; Musher, DM; Rossignol, JF | 1 |
Bouza, E; Burillo, A; Muñoz, P | 1 |
Koletar, SL; Mangino, JE; Stevenson, KB; Young, JD | 1 |
Garud, S; Hamill, RJ; Logan, N; Mehendiratta, V; Melgarejo, NA; Musher, DM | 1 |
Hemphill, A; Müller, J; Müller, N; Sterk, M | 1 |
Bronze, MS; Greenfield, R; Greenfield, RA; Salvaggio, M; Sud, B | 1 |
Felger, I; Hemphill, A; Ley, S; Müller, J; Müller, N | 1 |
Hehl, A; Hemphill, A; Müller, J; Müller, N; Nillius, D | 1 |
Burgess, AG; Dunn, LA; Kazimierczuk, Z; Krauer, KG; Upcroft, JA; Upcroft, P; Wright, JM | 1 |
Baines, SD; Freeman, J; Huscroft, GS; Todhunter, SL; Wilcox, MH | 1 |
Müller, J; Müller, N; Nillius, D | 1 |
Davids, BJ; Dunn, L; Eckmann, L; Gillin, FD; Lauwaet, T; Millman, M; Miyamoto, Y; Tejman-Yarden, N; Upcroft, JA | 1 |
Cheema, FH; Kanwal, S; Korsten, MA; Luthra, M; Majeed, UM; Rafiullah, F; Sohail, MR | 1 |
Johnson, S; Venugopal, AA | 1 |
Guerrant, RL; Hoffman, PS; Kolling, GL; Li, Y; Moore, JH; Riggins, MS; van Opstal, EJ; Warren, CA | 1 |
Criollo, CP; Granados, CE; Reveiz, L; Uribe, LG | 1 |
Müller, J; Müller, N; Schildknecht, P | 1 |
Ellis, J; Harkness, J; Marriott, D; Roberts, T; Stark, D | 1 |
Castillo-Villanueva, A; de la Mora-de la Mora, I; Enríquez-Flores, S; Figueroa-Salazar, R; García-Torres, I; Gómez-Manzo, S; Gutiérrez-Castrellón, P; Hernández-Alcántara, G; López-Velázquez, G; Marcial-Quino, J; Méndez, ST; Oria-Hernández, J; Reyes-Vivas, H; Torres-Arroyo, A; Vanoye-Carlo, A; Yépez-Mulia, L | 1 |
Johnson, S; Soriano, MM | 1 |
De la Mora-De la Mora, I; Enríquez-Flores, S; Fierro, F; Garcia-Torres, I; Gómez-Manzo, S; Marcial-Quino, J; Reyes-Vivas, H; Sierra-Palacios, E; Vanoye-Carlo, A | 1 |
Abdel-Magied, AA; El-Henawy, AA; Hammouda, MM; Mosbah, A | 1 |
Hernán, A; Jiménez, JC; Núñez, L; Pérez-Chacón, G; Pocaterra, LA; Rojas, E | 1 |
Leitsch, D | 1 |
Hemphill, A; Müller, J; Müller, N | 1 |
Iza, JA; Iza, SN; Olivera, MJ | 1 |
Cogdill, AG; Guevara, B | 1 |
Abdel Kader, A; El Amir, A; Farid, A; Madbouly, N; Rabee, I | 1 |
Agarwal, VK; Ashdhir, P; Chauhan, V; Goel, V; Jain, A; Jhajharia, A; Pokharna, R; Sharma, G | 1 |
Abd-Elsalam, SM; Bahaa, MM; Baiomy, N; Elnaggar, MH; Elsawy, AA; Gamal, RM; Habba, E; Salamah, AM; Shawky, D | 1 |
Muller, WJ; Newman, AM; Soneji, M; Toia, J | 1 |
8 review(s) available for nitazoxanide and metronidazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Anti-
Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Drug Delivery Systems; Drug Discovery; Drug Therapy, Combination; Gastrointestinal Tract; Giardia; Giardiasis; Humans; Nitroimidazoles | 2020 |
Antimicrobial therapy of Clostridium difficile-associated diarrhea.
Topics: Aged; Anti-Infective Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; Feces; Humans; Infant; Megacolon, Toxic; Metronidazole; Nitro Compounds; Risk Factors; Secondary Prevention; Thiazoles; Vancomycin | 2006 |
Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide.
Topics: Anti-Bacterial Agents; Bacterial Infections; Chloramphenicol; Drug Resistance, Microbial; Humans; Metronidazole; Nitro Compounds; Nitrofurantoin; Rifamycins; Rifaximin; Thiazoles; Tinidazole; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Current state of Clostridium difficile treatment options.
Topics: Anti-Bacterial Agents; Bacitracin; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Fusidic Acid; Humans; Metronidazole; Nitro Compounds; Secondary Prevention; Severity of Illness Index; Teicoplanin; Thiazoles; Treatment Outcome; Vancomycin | 2012 |
Drugs for treating giardiasis.
Topics: Adult; Albendazole; Antiparasitic Agents; Child; Giardiasis; Humans; Mebendazole; Metronidazole; Nitro Compounds; Randomized Controlled Trials as Topic; Thiazoles; Tinidazole | 2012 |
Treatment of Clostridium difficile infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Drug Therapy, Combination; Fidaxomicin; Gastrointestinal Diseases; Humans; Metronidazole; Nitro Compounds; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Thiazoles; Vancomycin | 2015 |
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath Tests; Clarithromycin; Culture Techniques; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Feces; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Nitro Compounds; Organometallic Compounds; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Rifabutin; Salicylates; Salvage Therapy; Serologic Tests; Stomach Neoplasms; Tetracycline; Thiazoles; Treatment Outcome; Urea | 2020 |
5 trial(s) available for nitazoxanide and metronidazole
Article | Year |
---|---|
Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru.
Topics: Anti-Infective Agents; Child; Child, Preschool; Diarrhea; Drug Administration Schedule; Female; Giardiasis; Humans; Male; Metronidazole; Nitro Compounds; Peru; Thiazoles; Treatment Outcome | 2001 |
Nitazoxanide for the treatment of Clostridium difficile colitis.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Nitro Compounds; Thiazoles | 2006 |
Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Nitro Compounds; Recurrence; Thiazoles; Treatment Failure | 2007 |
Evaluating the efficacy of nitazoxanide in uncomplicated amebic liver abscess.
Topics: Female; Humans; Lactation; Liver Abscess, Amebic; Metronidazole; Nitro Compounds; Pregnancy; Thiazoles | 2021 |
Nitazoxanide-based therapeutic regimen as a novel treatment for Helicobacter pylori infection in children and adolescents: a randomized trial.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitro Compounds; Proton Pump Inhibitors; Thiazoles; Treatment Outcome | 2022 |
38 other study(ies) available for nitazoxanide and metronidazole
Article | Year |
---|---|
Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni.
Topics: Acetyl Coenzyme A; Animals; Antiprotozoal Agents; Bacteria, Anaerobic; Campylobacter jejuni; Carbon Dioxide; Cloning, Molecular; Clostridium; Culture Media; Enzyme Inhibitors; Helicobacter pylori; Kinetics; L-Lactate Dehydrogenase; Magnetic Resonance Spectroscopy; Nitro Compounds; Parasites; Pyruvate Dehydrogenase Complex; Pyruvic Acid; Reverse Transcriptase Polymerase Chain Reaction; Thiamine Pyrophosphate; Thiazoles | 2007 |
A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides.
Topics: Amino Acid Sequence; Animals; Antiparasitic Agents; Chromatography, Affinity; Enzyme Inhibitors; Giardia lamblia; Molecular Sequence Data; Nitro Compounds; Nitroreductases; Parasitic Sensitivity Tests; Protozoan Proteins; Thiazoles | 2007 |
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States | 2007 |
Synthesis of benzologues of Nitazoxanide and Tizoxanide: a comparative study of their in vitro broad-spectrum antiprotozoal activity.
Topics: Antiprotozoal Agents; Giardia; Molecular Structure; Nitro Compounds; Plasmodium; Thiazoles; Trichomonas vaginalis | 2011 |
Synthesis and in vitro evaluation of new ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide against Entamoeba histolytica.
Topics: Antiprotozoal Agents; Cyclic N-Oxides; Entamoeba histolytica; Models, Molecular; Molecular Structure; Quinoxalines; Spectrum Analysis; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
2-acylamino-5-nitro-1,3-thiazoles: preparation and in vitro bioevaluation against four neglected protozoan parasites.
Topics: Animals; Antiprotozoal Agents; Drug Design; Humans; Protozoan Infections; Thiazoles | 2014 |
Synthesis of nitro(benzo)thiazole acetamides and in vitro antiprotozoal effect against amitochondriate parasites Giardia intestinalis and Trichomonas vaginalis.
Topics: Acetamides; Animals; Antiprotozoal Agents; Benzothiazoles; Cell Survival; Chlorocebus aethiops; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fructose-Bisphosphate Aldolase; Giardia lamblia; Molecular Dynamics Simulation; Molecular Structure; Nitro Compounds; Parasitic Sensitivity Tests; Structure-Activity Relationship; Thiazoles; Trichomonas vaginalis; Vero Cells | 2015 |
Synthesis, in vitro and in vivo giardicidal activity of nitrothiazole-NSAID chimeras displaying broad antiprotozoal spectrum.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiprotozoal Agents; Drug Design; Female; Giardia lamblia; Giardiasis; Humans; Leishmania; Mice; Nitro Compounds; Protozoan Infections; Thiazoles; Trichomonas vaginalis; Trypanosoma cruzi | 2017 |
The giardicidal activity of lobendazole, fabomotizole, tenatoprazole and ipriflavone: A ligand-based virtual screening and in vitro study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiprotozoal Agents; Benzimidazoles; Carbamates; Humans; In Vitro Techniques; Isoflavones; Ligands | 2021 |
Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitro Compounds; Pilot Projects; Thiazoles | 1998 |
Blastocystis hominis: neutral red supravital staining and its application to in vitro drug sensitivity testing.
Topics: Amebicides; Animals; Blastocystis hominis; Chloroquine; Coloring Agents; Humans; Metronidazole; Neutral Red; Nitro Compounds; Parasitic Sensitivity Tests; Paromomycin; Quinacrine; Staining and Labeling; Sulfamethoxazole; Tetracycline; Thiazoles; Trimethoprim | 2000 |
In vitro and in vivo activities of nitazoxanide against Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles; Vancomycin | 2000 |
Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Antiprotozoal Agents; Drug Resistance, Microbial; Giardia lamblia; Giardiasis; Humans; Male; Metronidazole; Nitro Compounds; Thiazoles; Treatment Outcome | 2001 |
Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori.
Topics: Biotransformation; Cloning, Molecular; DNA Damage; Drug Resistance, Bacterial; Escherichia coli; Helicobacter pylori; Ketone Oxidoreductases; Metronidazole; Mutation; Nitro Compounds; Nitrofurans; Nitroreductases; Oxidation-Reduction; Pyruvate Synthase; Substrate Specificity; Thiazoles | 2002 |
In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells.
Topics: Animals; Caco-2 Cells; Coculture Techniques; Giardia lamblia; Giardiasis; Humans; Metronidazole; Nitro Compounds; Parasitic Sensitivity Tests; Thiazoles; Tissue Culture Techniques | 2006 |
Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Clindamycin; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles | 2006 |
Nitazoxanide versus metronidazole for Clostridium difficile-associated colitis.
Topics: Aged; Animals; Anti-Bacterial Agents; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Nitro Compounds; Thiazoles; Treatment Outcome | 2007 |
Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole.
Topics: Animals; Antiprotozoal Agents; Clone Cells; DNA Primers; Drug Resistance; Gene Expression Regulation; Giardia lamblia; Metronidazole; Nitro Compounds; Protein Disulfide-Isomerases; Pyruvate Oxidase; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; Thiazoles | 2007 |
Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole.
Topics: Animals; Antigens, Protozoan; Antigens, Surface; Antiprotozoal Agents; Drug Resistance; Gene Expression Profiling; Giardia lamblia; Heat-Shock Proteins; Metronidazole; Mutation; Nitro Compounds; Nitroreductases; Oligonucleotide Array Sequence Analysis; Protein Disulfide-Isomerases; Protozoan Proteins; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles | 2008 |
Stable expression of Escherichia coli beta-glucuronidase A (GusA) in Giardia lamblia: application to high-throughput drug susceptibility testing.
Topics: Animals; Antiprotozoal Agents; Drug Evaluation, Preclinical; Escherichia coli; Escherichia coli Proteins; Genes, Reporter; Giardia lamblia; Glucuronidase; Metronidazole; Microbial Sensitivity Tests; Microbial Viability; Nitro Compounds; Pharmaceutical Preparations; Recombinant Proteins; Thiazoles | 2009 |
Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.
Topics: Anaerobiosis; Antitrichomonal Agents; Deoxyadenosines; Drug Resistance; Female; Humans; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles; Toyocamycin; Trichomonas vaginalis; Trichomonas Vaginitis | 2010 |
Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles | 2011 |
Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs.
Topics: Anti-Infective Agents; Escherichia coli; Giardia lamblia; Humans; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Nitroreductases; Oxidation-Reduction; Parasitic Sensitivity Tests; Thiazoles | 2011 |
Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia.
Topics: Animals; Antiprotozoal Agents; Cell Line; Drug Resistance; Furazolidone; Giardia lamblia; Giardiasis; Glucose; Metronidazole; Mice; Mice, Inbred C57BL; Nitro Compounds; Thiazoles; Tinidazole | 2011 |
Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Male; Metronidazole; Nitro Compounds; Recurrence; Thiazoles; Vancomycin | 2011 |
Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteroides; Cecum; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Intestines; Male; Metronidazole; Mice; Mice, Inbred C57BL; Nitro Compounds; Recurrence; Thiazoles; Treatment Outcome; Vancomycin | 2013 |
Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2).
Topics: Antiprotozoal Agents; Cloning, Molecular; DNA Damage; Escherichia coli; Gene Expression; Gene Expression Profiling; Genes, Reporter; Giardia lamblia; Humans; Metronidazole; Nitric Oxide; Nitro Compounds; Nitroreductases; Parasitic Sensitivity Tests; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles | 2013 |
Treatment failure in patients with chronic Blastocystis infection.
Topics: Adolescent; Adult; Antiprotozoal Agents; Blastocystis; Blastocystis Infections; Child; Chronic Disease; Cohort Studies; DNA, Protozoan; Drug Therapy, Combination; Feces; Female; Furazolidone; Genotype; Humans; Male; Metronidazole; Middle Aged; Nitro Compounds; Sequence Analysis, DNA; Thiazoles; Treatment Failure; Young Adult | 2014 |
Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia.
Topics: Albendazole; Antiprotozoal Agents; Axenic Culture; Cysteine; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Escherichia coli; Gene Expression; Giardia lamblia; Humans; Metronidazole; Mutation; Nitro Compounds; Omeprazole; Parasitic Sensitivity Tests; Protozoan Proteins; Recombinant Proteins; Spectrometry, Fluorescence; Thiazoles; Triose-Phosphate Isomerase; Trophozoites | 2014 |
Validation of housekeeping genes as an internal control for gene expression studies in Giardia lamblia using quantitative real-time PCR.
Topics: Animals; Antiprotozoal Agents; DNA Primers; Gene Expression Regulation; Genes, Essential; Giardia lamblia; Metronidazole; Nitro Compounds; Real-Time Polymerase Chain Reaction; Thiazoles | 2016 |
In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates.
Topics: Adult; Drug Resistance, Bacterial; Female; Humans; Metronidazole; Nitro Compounds; Thiazoles; Trichomonas vaginalis; Trichomonas Vaginitis | 2017 |
Coinfection with
Topics: Adult; Animals; Anthelmintics; Anti-HIV Agents; Antiprotozoal Agents; Coinfection; Diarrhea; Giardia lamblia; Giardiasis; HIV; HIV Infections; Humans; Hymenolepiasis; Hymenolepis diminuta; Hymenolepis nana; Male; Metronidazole; Nitro Compounds; Praziquantel; Thiazoles; Treatment Outcome; Weight Loss | 2017 |
Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
Topics: Albendazole; Animals; Anti-Infective Agents; Antiparasitic Agents; Antiprotozoal Agents; Antirheumatic Agents; Auranofin; Culture Media; Cysteine; Entamoeba histolytica; Furazolidone; Giardia lamblia; Metronidazole; Nitro Compounds; Parasites; Parasitic Sensitivity Tests; Thiazoles; Trichomonas vaginalis | 2017 |
Physiological aspects of nitro drug resistance in Giardia lamblia.
Topics: Antiparasitic Agents; Antiprotozoal Agents; Drug Resistance; Giardia lamblia; Giardiasis; Metronidazole; Nitro Compounds; Nitroreductases; Oxidoreductases; Oxygen; Thiazoles; Trophozoites | 2018 |
Giardiasis: report of a case refractory to treatment.
Topics: Adult; Albendazole; Antiprotozoal Agents; Furazolidone; Giardia lamblia; Giardiasis; Humans; Male; Metronidazole; Nitro Compounds; Nitroimidazoles; Thiazoles; Tinidazole; Treatment Failure | 2019 |
The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
Topics: Animals; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium parvum; Cytokines; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Ileum; Immunocompromised Host; Immunomodulation; Male; Metronidazole; Mice; Nitro Compounds; Parasite Load; Thiazoles | 2021 |
Metronidazole for treatment of norovirus in pediatric transplant recipients.
Topics: Child; Chronic Disease; Diarrhea; Gastroenteritis; Humans; Metronidazole; Norovirus; Retrospective Studies; Transplant Recipients | 2022 |